Guegan Cecile’s new insider position at Pfizer Inc. totals 149,505 shares held directly or indirectly. The disclosure gives investors a precise view of the Pfizer executive’s reported ownership position and identifies the stake as belonging to an executive vice president within the company.
Key Highlights
- Guegan Cecile serves as executive vice president of Pfizer Inc.
- The reported position is held directly or indirectly.
- Pfizer Inc. is identified in the record as PFE.
Guegan Cecile holds 149,505 Pfizer (NYSE: PFE) Inc. shares in a newly reported insider position, with ownership recorded directly or indirectly. The filing identifies her as an executive vice president of Pfizer Inc.
The position names Guegan Cecile as the holder and identifies Pfizer Inc. as the associated company. The record describes her ownership as direct or indirect. The position is categorized as a new insider position. The filing reports a specific share count for Guegan Cecile’s holding in Pfizer Inc. The position concerns Pfizer shares held by Guegan Cecile, either directly or indirectly.
FAQs
Q: How many Pfizer shares does Guegan Cecile hold?
A: Guegan Cecile holds 149,505 shares of Pfizer Inc. The position is recorded as being held directly or indirectly by the executive vice president.
Q: What is Guegan Cecile’s role at Pfizer?
A: Guegan Cecile is an executive vice president of Pfizer Inc. The filing identifies her in that role and reports her insider position.
Q: Is Guegan Cecile’s Pfizer position direct or indirect?
A: The reported Pfizer ownership is held directly or indirectly, as stated in the filing. It covers 149,505 shares held by Guegan Cecile, who is identified as an executive vice president of PFIZER INC.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.